Margarita E. Villarino
Public Health and Preventive Medicine
976 Lenzen Ave
San Jose, CA 95126
San Jose, CA 95126
Last Updated: 09/26/2026
Save publications for later
Sign Up
Not sure about your diagnosis?
Check Your Symptoms
Found 19 publications
Completion, safety, and efficacy of tuberculosis preventive treatment regimens containing rifampicin or rifapentine: an individual patient data network meta-analysis.
Journal: The Lancet. Respiratory medicine
Published: December 21, 2022
Genomic Epidemiology and Transmission Dynamics of Severe Acute Respiratory Syndrome Coronavirus 2 (SARS-CoV-2) in Congregate Healthcare Facilities in Santa Clara County, California.
Journal: Clinical infectious diseases : an official publication of the Infectious Diseases Society of America
Published: April 15, 2021
Zika Virus infection and Guillain-Barré syndrome in Northeastern Mexico: A case-control study.
Journal: PloS one
Published: October 31, 2019
Seroprevalence of spotted fever group rickettsiae in canines along the United States-Mexico border.
Journal: Zoonoses and public health
Published: November 18, 2018
Exposure to Latent Tuberculosis Treatment during Pregnancy. The PREVENT TB and the iAdhere Trials.
Journal: Annals of the American Thoracic Society
Published: February 03, 2018
Self-administered Versus Directly Observed Once-Weekly Isoniazid and Rifapentine Treatment of Latent Tuberculosis Infection: A Randomized Trial.
Journal: Annals of internal medicine
Published: November 09, 2017
Factors associated with non-completion of follow-up: 33-month latent tuberculous infection treatment trial.
Journal: The international journal of tuberculosis and lung disease : the official journal of the International Union against Tuberculosis and Lung Disease
Published: January 15, 2017
Three months of weekly rifapentine and isoniazid for treatment of Mycobacterium tuberculosis infection in HIV-coinfected persons.
Journal: AIDS (London, England)
Published: June 01, 2016
Factors Associated With Noncompletion of Latent Tuberculosis Infection Treatment: Experience From the PREVENT TB Trial in the United States and Canada.
Journal: Clinical infectious diseases : an official publication of the Infectious Diseases Society of America
Published: November 01, 2015
Three months of weekly rifapentine plus isoniazid is less hepatotoxic than nine months of daily isoniazid for LTBI.
Journal: The international journal of tuberculosis and lung disease : the official journal of the International Union against Tuberculosis and Lung Disease
Published: August 12, 2015
Treatment for preventing tuberculosis in children and adolescents: a randomized clinical trial of a 3-month, 12-dose regimen of a combination of rifapentine and isoniazid.
Journal: JAMA pediatrics
Published: January 13, 2015
Flu-like and Other Systemic Drug Reactions Among Persons Receiving Weekly Rifapentine Plus Isoniazid or Daily Isoniazid for Treatment of Latent Tuberculosis Infection in the PREVENT Tuberculosis Study.
Journal: Clinical infectious diseases : an official publication of the Infectious Diseases Society of America
Published: October 02, 2014
Last Updated: 09/26/2026